Pre-market: Pfizer’s FDA approval increases these stocks

But the scale of the pandemic generates tons of revenue. In a note released Monday, Morningstar analyst Karen Andersen said she sees sales of the Pfizer shot reaching $ 35 billion in 2021 and $ 39 billion in 2022. After that, she forecasts $ 2 billion in sales. annuals, as the most vulnerable continue to be shot.

FDA approval could further boost demand, although Andersen believes existing contracts will cover any spikes in interest.

“[The FDA] has now reviewed the six-month safety data from thousands of patients in the Phase 3 trial, “Andersen wrote.” This might encourage some people who were unsure of the vaccine’s long-term safety to to get vaccinated. “

“We also expect this approval to give more leverage to public and private organizations wishing to impose vaccination, including universities and hospitals,” Andersen wrote.

Watch this space: Pfizer and BioNTech are not the only stocks to benefit from vaccination campaigns that could safeguard economic recovery. Investors are also piling up in travel stocks and theaters following the news from the FDA.

Store closures expected to hit lowest level in 5 years

Store closures in America are expected to drop to their lowest level in five years in 2021, but that’s not really good news, reports my CNN Business colleague Nathaniel Meyersohn.

One factor: The industry, which has been hit in recent years by the switch to online shopping, saw a huge erasure last year, when closings were the highest on record.

Retailers in the United States are set to announce about 3,700 store closures this year, the lowest annual figure since 2016, according to commercial real estate data and analysis firm CoStar Group, which tracks public announcements. retail chains. The closures are estimated to be around 40 million square feet of space, the lowest since CoStar started keeping tabs in 2008.

Last year, 12,200 stores closed as the pandemic forced consumers to limit their visits.

Now, as the economic recovery sets in, the outlook is slightly brighter, at least for companies that weathered the storm.

Only 10 major retail companies have filed for bankruptcy this year, up from nearly 70 last year and 25-35 in the previous four years, Moody’s said in a recent research report.

“There is less pressure to close,” said Ken Fenyo, president of retail research and consulting firm Coresight Research. “You are seeing a strong comeback in the store. People are spending and are starting to come out. “

Why JD.com shares just climbed 15%

Shares of the Chinese e-commerce company jumped 15% in Hong Kong on Tuesday after the company beat investor expectations for its final quarter. JD.com said it added more than 32 million new users during the period, an all-time high.

That’s not all: the company’s stock also benefits from the Cathie Wood effect. Wood’s Ark Investment Management, which is closely watched by the Robinhood mob, revealed it had repurchased shares. Wood had previously warned of a “valuation reset” for Chinese tech stocks.

Not worth anything: The gains haven’t wiped out huge losses this year. JD.com shares are still down 18% in 2021, while Alibaba shares are down 28%. But following sharp declines last week, when China passed sweeping new rules on the collection and use of personal data and proposed major changes to curb anti-competitive behavior by large internet companies, the rebound indicates that some investors see good business.

JD.com, for its part, reassured its investors that the stricter regulatory regime would not hurt its prospects.

“We believe the regulatory goals are conducive to JD’s long-term business growth,” Lei Xu, the company’s chief marketing officer, told analysts after the results were released. “So far, our company has maintained steady growth while committed to applying best compliance practices.”

Following

Also today: US new home sales for July are released at 10 a.m. ET.